Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Till Bruckner"'
Autor:
Marguerite O’Riordan, Martin Haslberger, Carolina Cruz, Tarik Suljic, Martin Ringsten, Till Bruckner
Publikováno v:
Journal of Clinical and Translational Science, Vol 7 (2023)
Abstract Objectives: Assess the extent to which the clinical trial registration and reporting policies of 25 of the world’s largest public and philanthropic medical research funders meet best practice benchmarks as stipulated by the 2017 WHO Joint
Externí odkaz:
https://doaj.org/article/df211ce87336479c95b050c04fb646d9
Autor:
Sarai Mirjam Keestra, Florence Rodgers, Daphne Lenz, Rhiannon Osborne, Till Bruckner, Sean Lee
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-7 (2021)
Abstract Clinical trial transparency forms the foundation of evidence-based medicine, and trial sponsors, especially publicly funded institutions such as universities, have an ethical and scientific responsibility to make the results of clinical tria
Externí odkaz:
https://doaj.org/article/da17072dce1549acbe6893c5ac0d10d4
Autor:
Till Bruckner, Susanne Wieschowski, Miriam Heider, Susanne Deutsch, Natascha Drude, Ulf Tölch, André Bleich, René Tolba, Daniel Strech
Publikováno v:
PLoS ONE, Vol 17, Iss 8, p e0271976 (2022)
BackgroundExisting evidence indicates that a significant amount of biomedical research involving animals remains unpublished. At the same time, we lack standards for measuring the extent of results reporting in animal research. Publication rates may
Externí odkaz:
https://doaj.org/article/8e2e0dca53be4322bee2b3e52991eaeb
Autor:
Till Bruckner, Aminul Schuster, Belén Chavarría, Carolina Cruz, Karely Lizárraga, Ronak Borana, Tungamirai Ishe Bvute, Daniel Sánchez
This study provides a snapshot of the scale of legacy research waste in the UK. It assesses the current publication status of 145 clinical trials sponsored by ten major UK non-commercial sponsors that were completed or terminated in 2017. Following o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::20c37430be83161b9bcdeab1c95c0173
https://doi.org/10.1101/2023.05.03.23289434
https://doi.org/10.1101/2023.05.03.23289434
Autor:
Elise Gamertsfelder, Netzahualpilli Delgado Figueroa, Sarai Keestra, Alan Silva, Ronak Borana, Maximilian Siebert, Till Bruckner
Background/AimsClinical trial funders in the United States have the opportunity to promote transparency, reduce research waste, and prevent publication bias by adopting policies that require grantees to appropriately preregister trials and report the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b94b439bf314b2cedcdcda79410543a0
https://doi.org/10.1101/2023.04.03.23288059
https://doi.org/10.1101/2023.04.03.23288059
Autor:
Nico Riedel, Susanne Wieschowski, Till Bruckner, Martin R. Holst, Hannes Kahrass, Edris Nury, Joerg J. Meerpohl, Maia Salholz-Hillel, Daniel Strech
Publikováno v:
Journal of Clinical Epidemiology. 144:1-7
Timely publication of clinical trial results is central for evidence-based medicine. In this follow-up study we benchmark the performance of German university medical centers (UMCs) regarding timely dissemination of clinical trial results in recent y
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1262db0dbccacd3f509b870004f33036
https://doi.org/10.1016/j.jclinepi.2021.12.012
https://doi.org/10.1016/j.jclinepi.2021.12.012
Autor:
Till Bruckner, Samruddhi Yerunkar, Okan Basegmez, Ronak Borana, Belén Chavarría, Mayra Velarde, Nicholas J. DeVito
Non-publication, incomplete publication and excessively slow publication of clinical trial outcomes contribute to research waste and can harm patients. In this cohort study, we used publicClinicalTrials.govregistry records to identify 81 paediatric c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::117bd5ae281b7e5f4dcb70550c2b9da5
https://doi.org/10.1101/2023.01.17.23284683
https://doi.org/10.1101/2023.01.17.23284683
Publikováno v:
Clinical trials (London, England), 19(2), 217-223. SAGE Publications Ltd
Background: January 2019, the House of Commons’ Science and Technology Committee sent letters to UK universities admonishing them to achieve compliance with results reporting requirements for Clinical Trials of Investigative Medicinal Products by s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21a6bd3e96d4f7f604a898fe5dde4ea5
https://pubmed.ncbi.nlm.nih.gov/35168372
https://pubmed.ncbi.nlm.nih.gov/35168372
Publikováno v:
JAMA network open. American Medical Association
Importance: Research funders can reduce research waste and publication bias by requiring their grantees to register and report clinical trials. Objective: To determine the extent to which 21 major European research funders' efforts to reduce research
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c888785de828aa19b54ba1f96c7a01f4
Publikováno v:
JAMA Network Open
This cross-sectional study compares the duration of postapproval trials with that of the pivotal trials used as the basis for the US Food and Drug Administration’s (FDA’s) approval for all indications receiving accelerated approval from 2009-2018
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::084f03653ce3bc7c30a77e9ce82d3af7
https://pubmed.ncbi.nlm.nih.gov/34751764
https://pubmed.ncbi.nlm.nih.gov/34751764